A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sulfamerazine | CAS 127-79-7 - Request Quote

Picture of Sulfamerazine

Sulfamerazine

SZ CAT No:SZ-S101001
CAS No
127-79-7
Mol.F.
C11H12N4O2S
Mol.Wt.
264.3
Inv. Status
In Stock
Rel. CAS No24540-81-6 (HCl salt) ; 127-58-2 (Na salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sulfamerazine is chemically 4-Amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide. Sulfamerazine is supplied with detailed characterization data compliant with regulatory guideline. Sulfamerazine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sulfamerazine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 127-79-7

Purchase 127-79-7

Order 127-79-7

Enquire 127-79-7

price of 127-79-7

127-79-7 Supplier

127-79-7 Manufacturer

127-79-7 Exporter

buy high quality Sulfamerazine

Purchase Sulfamerazine

Sulfamerazine suppliers

Sulfamerazine manufacturers

Sulfamerazine price

Order Sulfamerazine

Enquire Sulfamerazine

Sulfamerazine cost

Sulfamerazine Supplier

Sulfamerazine Distributor

Sulfamerazine for Method Validation

Sulfamerazine Reference Standard

Sulfamerazine for ANDA Filing

Sulfamerazine for Forced Degradation Studies

Sulfamerazine Identification Standards

Sulfamerazine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,